Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa
Loading...
Date
2013
Journal Title
Journal ISSN
Volume Title
Publisher
Lippincott Williams & Wilkins
Abstract
This study evaluated the outcome of first-line antiretroviral
therapy among 35 Ghanaians with occult
HBV/HIV co-infection, comparing them over
2 years to 120 patients with HBsAgR HBV/HIV
co-infection and 230 patients without HBV coinfection.
Increases in CD4 cell count and BMI
were similar, whereas elevations of hepatic transaminases
were more frequent in both the occult
HBVand HBsAgR patients. Occult HBV/HIV coinfection
appears not to impact adversely on
response to antiretroviral therapy in Ghana.
Description
An article published by Lippincott Williams & Wilkins and available at DOI:10.1097/QAD.0b013e3283589879
Keywords
Citation
Lippincott Williams & Wilkins Vol 27 No 1